Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07131241) titled 'PH-DyPred: A Multimodal Dynamic Risk Prediction Study in Pulmonary Hypertension' on Aug. 6.

Study Type: Observational [Patient Registry]

Primary Sponsor: First Affiliated Hospital of Fujian Medical University

Condition: Pulmonary Hypertension

Recruitment Status: Recruiting

Date of First Enrollment: June 27, 2025

Target Sample Size: 1000

Countries of Recruitment: China

To know more, visit https://clinicaltrials.gov/ct2/show/NCT07131241

Published by HT Digital Content Services with permission from Health Daily Digest....